SlideShare a Scribd company logo
1 of 9
Emergence & Evolution of GHIs




                                Carlos Bruen & Ruairí Brugha
                                  Royal College of Surgeons in Ireland
Aims & Methods of Study

Analysis of the emergence & evolution of GHIs
•GHIs: GAVI Alliance, Global Fund, PEPFAR, World Bank MAP
•Focus at the global level and global-country interface
•Focus on issues of partnership, governance, influence of individuals, organizations and
networks in the evolving design and policy priorities of GHIs

Methods
•Documentary Reviews
•Stakeholder mapping & in-depth telephone interviews of purposively
selected individuals (n=36) (2009-11)
•Recorded, transcribed, anonymised, thematic analysis

Interviewee Characteristics
•Constituency Affiliation at time of interview
•Constituency Crossing
•Multiple Roles
Actor-Centered Analysis


                                                                       Health Policy Analysis

                                                                       •Global Health
       Object of Research: GHIs                                        Governance

      -New institutions within the field of Global Health              •Comparative
      Governance that drive a global agenda at the
      country level                                                    Institutional Analysis

      -Comprised of individuals and organizations
      across multiple constituencies, aim of which is                  •Network Analysis
      to address collective action problems

                                                                       •Strategic Action
                                                                       Theory



Cf: Adam & Krisei (2007); Fligstein & McAdam (2011); Hein et al (2009);Jackson (2010); Walt & Gilson (1994)
General Overview - Actors in GHI
Emergence
• Modus operandi rooted in the influence of different stakeholders at the time of GHI
  formation
                            PEPFAR                            Global Fund                           GAVI Alliance
Policy                                                                                     Semi-open - influential small, closed
                                                    Open - Multiple policy communities
Community       Closed - Small policy community
                                                    within broad issue network
                                                                                           policy community in broader issue
                                                                                           network
Type
                                                    •Core: Transitional Working Group      •Core: PATH, vaccine reps from
Key Actors      •Core: US Federal agencies          •G8(financial), African govs           multilateral institutions, private
                                                    (symbolic)                             sector and Gates Foundation
in GHI          •US Congress negotiations &
                                                    •Consultations with countries, civil   •Reps from European donor orgs
                NGO/private sector lobbying
design                                              soc , private sector (+ traditional    •Consultation through personal
                                                    actors)                                networks
                •Global Fund slow in releasing      •Need for a ‘war chest’                •Counteract falling priority of
                finances, PEPFAR as emergency                                              vaccines & UN systems’
Cited           response and ‘catalyst’.            •Address failures of existing          weaknesses
                                                    strategies, incl. UN system
Justification   •Soft power focus on Africa
                                                    •Involve public and private
                                                                                           • Involve public + private
s               •Need to improve coordination of    stakeholders
                                                                                           stakeholders (eg WHO) in an
                US agencies                                                                ‘alliance’ to get buy-in
                                                    •‘Lean and Mean’, ‘quick wins’         •‘Lean and Mean’
                •1/3 spending for abstinence only    •No country presence
                programs, anti-prostitution pledge & •Worked with (separate to) UN         •No country presence but use EPI
                no funding to needle exchange       agencies                               (immunisation) infrastructure
Examples of     programs                            •Focus on 3 diseases, but early        •Focus on new and increased
policy          •System preference for US-NGOs      focus on HIV/AIDS treatment scale-     access to existing vaccines
outcomes        •Top-down influence on national     up                                     •Use performance-based funding
                reforms                             •Use performance-based funding         •Increased NGO role for service
                •Greater NGO role in service        •Increased NGO role for service        delivery
                delivery                            delivery and governance
Case Study 1: Global Fund & Civil Society:
 From Transnational Advocacy to Actors in
 Governance
• Transnational civil society treatment advocacy network formed throughout
  1990s
• Influence over negotiations
      • Directly though high-level cross-constituency ties to political and bureaucratic elites
      • Indirectly though wider network tactics (information, symbolic, leverage and accountability
        tactics)
      • Reflected in resulting Global Fund architecture and priorities

• Influence over evolution of structure and policies
      • Including i) communities voting rights; ii) dual-track financing; iii) pressure to approve
        procurement of generic medicines; iv) widening of original GF framework despite high-level
        opposition; v) increasing influence of Southern NGOs

• Enduring Challenges
      • Perceptions of undemocratic processes and limited stakeholder representation by a small
        number of NGOs in global and country Fund governance structures
      • ‘Civil society’ complexity, masking divisions and rivalries between NGOs at the global and
        country levels and the divisions of lab our that have emerged
      • Managing multiple ‘upwards’ +‘downwards’ lines of accountability + avoiding donor co-
        option
Case Study 2: GAVI Alliance as a Strategic
Action Field
• What precipitates major institutional change?
• Context of GAVI Emergence: Collapse of Child Vaccine Initiative, breakdown
  in actor relations & low priority for vaccines
• Phoenix rising: Formation of a small immunization community that vied for
  strategic advantage in GAVI design phase through use of strategies to
  increase financial and social capital and get wider buy-in
• Incumbents Challenge: Processes that led to an increased attention to HSS
  as GAVI evolved included:
   • Emergence of evidence on health systems’ weaknesses, undermining vertical approaches;
   • Changes in GAVI governance structures, actor composition and relative power; and increases in donor
     contributions and HSS financing through IFFIm;
   • Opening of ‘policy windows’ and political opportunities to advance broader health systems’ support

• Settlement: While partially successful, the challenge was undermined by:
   • Weak evidence of the benefits of investments in health systems strengthening, reinforcing the Gates
     Foundation’s support at Board level for vertical investments;
   • Fragmented health systems coalitions;
   • The global financial crisis and reduced donor financing for HSS.
GHIs & HSS: An Uncomfortable Co-
Existence
• Global Fund
  • Strong opposition to deviating funds from three diseases and hit by a fiduciary, financial and
    management crisis - aid effectiveness (a pre-condition of HSS) being overtaken by more
    immediate restructuring and financing concerns (McCoy et al, 2012)
  • Assessment of systems effect remains built in to GF funding framework

• GAVI
  • While HSS remains an important strategy, some Board members opposed to departing from
    GAVI goals. Negotiated compromise resulted in a selective HSS strategic goal being
    adopted, Strategic Goal 2 (2011-15)

• Consensus has been lacking on HSS, while opposition against financing a
  perceived unmeasurable HSS ‘black hole’ remains strong
  • Influential political coalitions or resource mobilization for HSS has not been forthcoming,
    while HSS policy communities remain fragmented.
  • HSS perceived to have a weak evidence base and measurable indicators of impact are
    lacking or highly contested

• GHIs and donors have shifted from speed and volume to effectiveness of
  disbursements – may lend support for shorter-term performance indicators
Conclusion: GHIs, HSS & UHC
• Strong health systems fundamental to achieving UHC. However, HSS rhetoric not matched
  by financial commitments (IHME 2011; Hafner & Shiffman, 2012)




• UHC: How might it be realised in this context?
References

• Adam, Silke, and Hanspeter Kriesi. "The Network Approach." In Theories of the Policy Process, edited by
  Paul A. Sabatier, 129-54. Boulder, CO: Westview Press, 2007
• Brugha, Ruairi. "Global Health Initiatives and Public Health Policy." In International Encyclopedia of Public
  Health, edited by Kris and Heggenhougen and Stella Quah, 72-81. San Diego: Academic Press, 2008.
• Fligstein, Neil, and Doug McAdam. "Toward a General Theory of Strategic Action Fields*." Sociological
  Theory 29, no. 1 (2011): 1-26.
• Hafner, Tamara, and Jeremy Shiffman. "The Emergence of Global Attention to Health Systems
  Strengthening." Health Policy and Planning (2012)
• Hein, Wolfgang, Scott Burris, and Clifford Shearing. "Conceptual Models for Global Health Governance."
  In Making Sense of Global Health Governance: A Policy Perspective, edited by Kent Buse, Wolfgang Hein and
  Nick Drager, 72-98. Basingstoke: Palgrave Macmillan, 2009.
• IHME. "Financing Global Health 2011: Continued Growth as Mdg Dealine Approaches ". Seattle, WA: Institute of
  Helath Metrics & Evaluation, 2011
• Jackson, Gregory. "Actors & Institutions." In The Oxford Handbook of Comparative Institutional Analysis,
  edited by Glenn Morgan, John Campbell, Colin Crouch, Ove Kai Pedersen and Richard Whitley, 63-86. Oxford:
  Oxford University Press, 2010
• McCoy, David, Carlos Bruen, Peter Hill, and Dominique Kerouedan. "The Global Fund: What Next for
  Aid Effectivness and Health Systems Strengthening?". Nairobi, Kenya: Aidspan, 2012
• Walt, Gill, and Lucy Gilson. "Reforming the Health Sector in Developing Countries: The Central Role of
  Policy Analysis." Health Policy & Planning 9 (1994): 353-70.

More Related Content

Similar to Emergence and Evolution of GHIs

Presidential Peace Conference: Polio Partnerships and Beyond
Presidential Peace Conference: Polio Partnerships and BeyondPresidential Peace Conference: Polio Partnerships and Beyond
Presidential Peace Conference: Polio Partnerships and BeyondRotary International
 
The state in global health (focus on LICs/MICs)
The state in global health (focus on LICs/MICs)The state in global health (focus on LICs/MICs)
The state in global health (focus on LICs/MICs)Albert Domingo
 
ICCM_Sara Riese_10.16.13
ICCM_Sara Riese_10.16.13ICCM_Sara Riese_10.16.13
ICCM_Sara Riese_10.16.13CORE Group
 
Oxfam's use of evidence for influencing - Irene Guijt
Oxfam's use of evidence for influencing - Irene GuijtOxfam's use of evidence for influencing - Irene Guijt
Oxfam's use of evidence for influencing - Irene GuijtGlobal Development Institute
 
8-26 HIE Workgroup Meeting
8-26 HIE Workgroup Meeting8-26 HIE Workgroup Meeting
8-26 HIE Workgroup MeetingBrian Ahier
 
Sabin SIF Program theory I.16
Sabin SIF Program theory I.16Sabin SIF Program theory I.16
Sabin SIF Program theory I.16Mike McQuestion
 
Advocacy inemergencies
Advocacy inemergenciesAdvocacy inemergencies
Advocacy inemergenciesMohammad Noor
 
Preventing epidemics and impact - BCG.pdf
Preventing epidemics and impact - BCG.pdfPreventing epidemics and impact - BCG.pdf
Preventing epidemics and impact - BCG.pdfMSawant2
 
Meessen universal health coverage
Meessen universal health coverageMeessen universal health coverage
Meessen universal health coverageNewGHPC
 
Data, evidence and access to information
Data, evidence and access to informationData, evidence and access to information
Data, evidence and access to informationALNAP
 
SM 185A Patient Advocacy
SM 185A Patient AdvocacySM 185A Patient Advocacy
SM 185A Patient AdvocacyBest Practices
 
Championing the Diffusion of Community Forestry Through Pathways of Influence...
Championing the Diffusion of Community Forestry Through Pathways of Influence...Championing the Diffusion of Community Forestry Through Pathways of Influence...
Championing the Diffusion of Community Forestry Through Pathways of Influence...CIFOR-ICRAF
 
Scaling up nutrition: what and how
Scaling up nutrition: what and howScaling up nutrition: what and how
Scaling up nutrition: what and howTransform Nutrition
 
14 april diversification izabella toth [compatibility mode]
14 april diversification izabella toth [compatibility mode]14 april diversification izabella toth [compatibility mode]
14 april diversification izabella toth [compatibility mode]Olga Kozhaeva
 
4 141211053449-conversion-gate01
4 141211053449-conversion-gate014 141211053449-conversion-gate01
4 141211053449-conversion-gate01Enock Masvosvere
 
Vibrant Communities Canada: Measuring Impact
Vibrant Communities Canada: Measuring Impact Vibrant Communities Canada: Measuring Impact
Vibrant Communities Canada: Measuring Impact Social Finance
 
Integrating Community-Based Strategies into Existing Health Systems_Will Stor...
Integrating Community-Based Strategies into Existing Health Systems_Will Stor...Integrating Community-Based Strategies into Existing Health Systems_Will Stor...
Integrating Community-Based Strategies into Existing Health Systems_Will Stor...CORE Group
 

Similar to Emergence and Evolution of GHIs (20)

Presidential Peace Conference: Polio Partnerships and Beyond
Presidential Peace Conference: Polio Partnerships and BeyondPresidential Peace Conference: Polio Partnerships and Beyond
Presidential Peace Conference: Polio Partnerships and Beyond
 
Evidence and the SDGs
Evidence and the SDGsEvidence and the SDGs
Evidence and the SDGs
 
The state in global health (focus on LICs/MICs)
The state in global health (focus on LICs/MICs)The state in global health (focus on LICs/MICs)
The state in global health (focus on LICs/MICs)
 
ICCM_Sara Riese_10.16.13
ICCM_Sara Riese_10.16.13ICCM_Sara Riese_10.16.13
ICCM_Sara Riese_10.16.13
 
Oxfam's use of evidence for influencing - Irene Guijt
Oxfam's use of evidence for influencing - Irene GuijtOxfam's use of evidence for influencing - Irene Guijt
Oxfam's use of evidence for influencing - Irene Guijt
 
8-26 HIE Workgroup Meeting
8-26 HIE Workgroup Meeting8-26 HIE Workgroup Meeting
8-26 HIE Workgroup Meeting
 
Evaluating The California Endowment Clinic Consortia Policy and Advocacy Prog...
Evaluating The California Endowment Clinic Consortia Policy and Advocacy Prog...Evaluating The California Endowment Clinic Consortia Policy and Advocacy Prog...
Evaluating The California Endowment Clinic Consortia Policy and Advocacy Prog...
 
Sabin SIF Program theory I.16
Sabin SIF Program theory I.16Sabin SIF Program theory I.16
Sabin SIF Program theory I.16
 
Advocacy inemergencies
Advocacy inemergenciesAdvocacy inemergencies
Advocacy inemergencies
 
Shaping future health markets: Reflections from Bellagio
Shaping future health markets: Reflections from BellagioShaping future health markets: Reflections from Bellagio
Shaping future health markets: Reflections from Bellagio
 
Preventing epidemics and impact - BCG.pdf
Preventing epidemics and impact - BCG.pdfPreventing epidemics and impact - BCG.pdf
Preventing epidemics and impact - BCG.pdf
 
Meessen universal health coverage
Meessen universal health coverageMeessen universal health coverage
Meessen universal health coverage
 
Data, evidence and access to information
Data, evidence and access to informationData, evidence and access to information
Data, evidence and access to information
 
SM 185A Patient Advocacy
SM 185A Patient AdvocacySM 185A Patient Advocacy
SM 185A Patient Advocacy
 
Championing the Diffusion of Community Forestry Through Pathways of Influence...
Championing the Diffusion of Community Forestry Through Pathways of Influence...Championing the Diffusion of Community Forestry Through Pathways of Influence...
Championing the Diffusion of Community Forestry Through Pathways of Influence...
 
Scaling up nutrition: what and how
Scaling up nutrition: what and howScaling up nutrition: what and how
Scaling up nutrition: what and how
 
14 april diversification izabella toth [compatibility mode]
14 april diversification izabella toth [compatibility mode]14 april diversification izabella toth [compatibility mode]
14 april diversification izabella toth [compatibility mode]
 
4 141211053449-conversion-gate01
4 141211053449-conversion-gate014 141211053449-conversion-gate01
4 141211053449-conversion-gate01
 
Vibrant Communities Canada: Measuring Impact
Vibrant Communities Canada: Measuring Impact Vibrant Communities Canada: Measuring Impact
Vibrant Communities Canada: Measuring Impact
 
Integrating Community-Based Strategies into Existing Health Systems_Will Stor...
Integrating Community-Based Strategies into Existing Health Systems_Will Stor...Integrating Community-Based Strategies into Existing Health Systems_Will Stor...
Integrating Community-Based Strategies into Existing Health Systems_Will Stor...
 

More from GlobalHealthObserver

Global Health Initiatives and the South African health system
Global Health Initiatives and the South African health systemGlobal Health Initiatives and the South African health system
Global Health Initiatives and the South African health systemGlobalHealthObserver
 
Influence of GHIs on Mozambique public health system
Influence of GHIs on Mozambique public health systemInfluence of GHIs on Mozambique public health system
Influence of GHIs on Mozambique public health systemGlobalHealthObserver
 
People's Health Assembly 2012: Global Health Initiatives, Civil Society and t...
People's Health Assembly 2012: Global Health Initiatives, Civil Society and t...People's Health Assembly 2012: Global Health Initiatives, Civil Society and t...
People's Health Assembly 2012: Global Health Initiatives, Civil Society and t...GlobalHealthObserver
 
Gorik Ooms at Aids2012: Future Global Priorities or Beyond 2015
Gorik Ooms at Aids2012: Future Global Priorities or Beyond 2015Gorik Ooms at Aids2012: Future Global Priorities or Beyond 2015
Gorik Ooms at Aids2012: Future Global Priorities or Beyond 2015GlobalHealthObserver
 

More from GlobalHealthObserver (8)

Global Health Initiatives and the South African health system
Global Health Initiatives and the South African health systemGlobal Health Initiatives and the South African health system
Global Health Initiatives and the South African health system
 
Influence of GHIs on Mozambique public health system
Influence of GHIs on Mozambique public health systemInfluence of GHIs on Mozambique public health system
Influence of GHIs on Mozambique public health system
 
People's Health Assembly 2012: Global Health Initiatives, Civil Society and t...
People's Health Assembly 2012: Global Health Initiatives, Civil Society and t...People's Health Assembly 2012: Global Health Initiatives, Civil Society and t...
People's Health Assembly 2012: Global Health Initiatives, Civil Society and t...
 
Gorik Ooms at Aids2012: Future Global Priorities or Beyond 2015
Gorik Ooms at Aids2012: Future Global Priorities or Beyond 2015Gorik Ooms at Aids2012: Future Global Priorities or Beyond 2015
Gorik Ooms at Aids2012: Future Global Priorities or Beyond 2015
 
GHIs in South Africa
GHIs in South AfricaGHIs in South Africa
GHIs in South Africa
 
GHIs in Mozambique
GHIs in Mozambique GHIs in Mozambique
GHIs in Mozambique
 
GHI Angola overview
GHI Angola overviewGHI Angola overview
GHI Angola overview
 
Global Level Research Overview
Global Level Research OverviewGlobal Level Research Overview
Global Level Research Overview
 

Emergence and Evolution of GHIs

  • 1. Emergence & Evolution of GHIs Carlos Bruen & Ruairí Brugha Royal College of Surgeons in Ireland
  • 2. Aims & Methods of Study Analysis of the emergence & evolution of GHIs •GHIs: GAVI Alliance, Global Fund, PEPFAR, World Bank MAP •Focus at the global level and global-country interface •Focus on issues of partnership, governance, influence of individuals, organizations and networks in the evolving design and policy priorities of GHIs Methods •Documentary Reviews •Stakeholder mapping & in-depth telephone interviews of purposively selected individuals (n=36) (2009-11) •Recorded, transcribed, anonymised, thematic analysis Interviewee Characteristics •Constituency Affiliation at time of interview •Constituency Crossing •Multiple Roles
  • 3. Actor-Centered Analysis Health Policy Analysis •Global Health Object of Research: GHIs Governance -New institutions within the field of Global Health •Comparative Governance that drive a global agenda at the country level Institutional Analysis -Comprised of individuals and organizations across multiple constituencies, aim of which is •Network Analysis to address collective action problems •Strategic Action Theory Cf: Adam & Krisei (2007); Fligstein & McAdam (2011); Hein et al (2009);Jackson (2010); Walt & Gilson (1994)
  • 4. General Overview - Actors in GHI Emergence • Modus operandi rooted in the influence of different stakeholders at the time of GHI formation PEPFAR Global Fund GAVI Alliance Policy Semi-open - influential small, closed Open - Multiple policy communities Community Closed - Small policy community within broad issue network policy community in broader issue network Type •Core: Transitional Working Group •Core: PATH, vaccine reps from Key Actors •Core: US Federal agencies •G8(financial), African govs multilateral institutions, private (symbolic) sector and Gates Foundation in GHI •US Congress negotiations & •Consultations with countries, civil •Reps from European donor orgs NGO/private sector lobbying design soc , private sector (+ traditional •Consultation through personal actors) networks •Global Fund slow in releasing •Need for a ‘war chest’ •Counteract falling priority of finances, PEPFAR as emergency vaccines & UN systems’ Cited response and ‘catalyst’. •Address failures of existing weaknesses strategies, incl. UN system Justification •Soft power focus on Africa •Involve public and private • Involve public + private s •Need to improve coordination of stakeholders stakeholders (eg WHO) in an US agencies ‘alliance’ to get buy-in •‘Lean and Mean’, ‘quick wins’ •‘Lean and Mean’ •1/3 spending for abstinence only •No country presence programs, anti-prostitution pledge & •Worked with (separate to) UN •No country presence but use EPI no funding to needle exchange agencies (immunisation) infrastructure Examples of programs •Focus on 3 diseases, but early •Focus on new and increased policy •System preference for US-NGOs focus on HIV/AIDS treatment scale- access to existing vaccines outcomes •Top-down influence on national up •Use performance-based funding reforms •Use performance-based funding •Increased NGO role for service •Greater NGO role in service •Increased NGO role for service delivery delivery delivery and governance
  • 5. Case Study 1: Global Fund & Civil Society: From Transnational Advocacy to Actors in Governance • Transnational civil society treatment advocacy network formed throughout 1990s • Influence over negotiations • Directly though high-level cross-constituency ties to political and bureaucratic elites • Indirectly though wider network tactics (information, symbolic, leverage and accountability tactics) • Reflected in resulting Global Fund architecture and priorities • Influence over evolution of structure and policies • Including i) communities voting rights; ii) dual-track financing; iii) pressure to approve procurement of generic medicines; iv) widening of original GF framework despite high-level opposition; v) increasing influence of Southern NGOs • Enduring Challenges • Perceptions of undemocratic processes and limited stakeholder representation by a small number of NGOs in global and country Fund governance structures • ‘Civil society’ complexity, masking divisions and rivalries between NGOs at the global and country levels and the divisions of lab our that have emerged • Managing multiple ‘upwards’ +‘downwards’ lines of accountability + avoiding donor co- option
  • 6. Case Study 2: GAVI Alliance as a Strategic Action Field • What precipitates major institutional change? • Context of GAVI Emergence: Collapse of Child Vaccine Initiative, breakdown in actor relations & low priority for vaccines • Phoenix rising: Formation of a small immunization community that vied for strategic advantage in GAVI design phase through use of strategies to increase financial and social capital and get wider buy-in • Incumbents Challenge: Processes that led to an increased attention to HSS as GAVI evolved included: • Emergence of evidence on health systems’ weaknesses, undermining vertical approaches; • Changes in GAVI governance structures, actor composition and relative power; and increases in donor contributions and HSS financing through IFFIm; • Opening of ‘policy windows’ and political opportunities to advance broader health systems’ support • Settlement: While partially successful, the challenge was undermined by: • Weak evidence of the benefits of investments in health systems strengthening, reinforcing the Gates Foundation’s support at Board level for vertical investments; • Fragmented health systems coalitions; • The global financial crisis and reduced donor financing for HSS.
  • 7. GHIs & HSS: An Uncomfortable Co- Existence • Global Fund • Strong opposition to deviating funds from three diseases and hit by a fiduciary, financial and management crisis - aid effectiveness (a pre-condition of HSS) being overtaken by more immediate restructuring and financing concerns (McCoy et al, 2012) • Assessment of systems effect remains built in to GF funding framework • GAVI • While HSS remains an important strategy, some Board members opposed to departing from GAVI goals. Negotiated compromise resulted in a selective HSS strategic goal being adopted, Strategic Goal 2 (2011-15) • Consensus has been lacking on HSS, while opposition against financing a perceived unmeasurable HSS ‘black hole’ remains strong • Influential political coalitions or resource mobilization for HSS has not been forthcoming, while HSS policy communities remain fragmented. • HSS perceived to have a weak evidence base and measurable indicators of impact are lacking or highly contested • GHIs and donors have shifted from speed and volume to effectiveness of disbursements – may lend support for shorter-term performance indicators
  • 8. Conclusion: GHIs, HSS & UHC • Strong health systems fundamental to achieving UHC. However, HSS rhetoric not matched by financial commitments (IHME 2011; Hafner & Shiffman, 2012) • UHC: How might it be realised in this context?
  • 9. References • Adam, Silke, and Hanspeter Kriesi. "The Network Approach." In Theories of the Policy Process, edited by Paul A. Sabatier, 129-54. Boulder, CO: Westview Press, 2007 • Brugha, Ruairi. "Global Health Initiatives and Public Health Policy." In International Encyclopedia of Public Health, edited by Kris and Heggenhougen and Stella Quah, 72-81. San Diego: Academic Press, 2008. • Fligstein, Neil, and Doug McAdam. "Toward a General Theory of Strategic Action Fields*." Sociological Theory 29, no. 1 (2011): 1-26. • Hafner, Tamara, and Jeremy Shiffman. "The Emergence of Global Attention to Health Systems Strengthening." Health Policy and Planning (2012) • Hein, Wolfgang, Scott Burris, and Clifford Shearing. "Conceptual Models for Global Health Governance." In Making Sense of Global Health Governance: A Policy Perspective, edited by Kent Buse, Wolfgang Hein and Nick Drager, 72-98. Basingstoke: Palgrave Macmillan, 2009. • IHME. "Financing Global Health 2011: Continued Growth as Mdg Dealine Approaches ". Seattle, WA: Institute of Helath Metrics & Evaluation, 2011 • Jackson, Gregory. "Actors & Institutions." In The Oxford Handbook of Comparative Institutional Analysis, edited by Glenn Morgan, John Campbell, Colin Crouch, Ove Kai Pedersen and Richard Whitley, 63-86. Oxford: Oxford University Press, 2010 • McCoy, David, Carlos Bruen, Peter Hill, and Dominique Kerouedan. "The Global Fund: What Next for Aid Effectivness and Health Systems Strengthening?". Nairobi, Kenya: Aidspan, 2012 • Walt, Gill, and Lucy Gilson. "Reforming the Health Sector in Developing Countries: The Central Role of Policy Analysis." Health Policy & Planning 9 (1994): 353-70.